Skip Navigation

ClearSkin Category Archive - Blog

Effective management of vitiligo

August 16, 2012

The most effective management for vitiligo includes phototherapy and combination therapy, according to updated guidelines from the writing group of the Vitiligo European Task Force (VETF), which were accepted for publication and published online August 3 in the British Journal of Dermatology.

vitiligo treatment

The European Academy of Dermatology and Venereology and the Union Européenne des Médecins Spécialistes collaborated with the VETF in developing the new evidence- and expert-based guidelines for vitiligo.

“Vitiligo is a disease lacking definitive and completely effective therapies,” writes A. Taïeb, MD, from Service de Dermatologie, CHU de Bordeaux, France, and colleagues. “Phototherapy and combined treatments are the most effective treatments. Therapy should stop the progression of the lesions and provide complete or almost complete repigmentation to be satisfactory for the patient.”

Worldwide prevalence of vitiligo is 0.5%, without preference for specific age groups, races, or gender.

Management Recommendations

The reviewers recommend the following principles of management for segmental vitiligo or limited nonsegmental vitiligo (involving less than 2% – 3% of body surface):

  • First-line treatment should be to avoid triggering factors and to use local agents such as corticosteroids or calcineurin inhibitors.
  • Second-line treatment should be localized narrow-band ultraviolet B (NB-UVB) radiation (311 nm), preferably with the excimer monochromatic lamp or laser.
  • Third-line treatment for patients left with cosmetically unsatisfactory repigmentation on visible areas after first- or second-line therapy is to consider use of surgical techniques.

The reviewers recommend the following principles of management for nonsegmental vitiligo:

  • First-line management is to avoid triggering or aggravating factors and to stabilize the patient with NB-UVB therapy for at least 3 months. Patients who respond to NB-UVB should continue this treatment for 9 months or more. An additional consideration is to combine localized UVB therapy with systemic or topical therapies.


Dermatology News – developments at Clear Skin (newsletter)

March 9, 2012

The most recent Clear Skin newsletter – Dermatology News – provides all the latest news from the UK’s leading specialist phototherapy skin clinic.Dermatology News - Home Phototherapy Service Update

Providing full details on the new Clear Skin Home Phototherapy Service and guidance to consultants on how to refer private patients , the newsletter also sets out for patients the benefits of the unique Home Phototherapy Service which provides the very best phototherapy equipment for sale or hire with ongoing medical supervision and support.

This edition of Dermatology News also provides testimonials from existing Home Phototherapy Service users giving details of the difference treatment in their own home has made to them.

To read Dermatology News from The Clearskin Dermatology Treatment Clinic - click here